US 12,233,052 B2
Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
Sharada Labadie, Sunnyvale, CA (US); Jun Liang, Los Altos, CA (US); Daniel Fred Ortwine, San Ramon, CA (US); Xiaojing Wang, Belmont, CA (US); Jason Zbieg, Montara, CA (US); Birong Zhang, Union City, CA (US); Simon Charles Goodacre, Harlow (GB); Nicholas Charles Ray, Great Dunnow (GB); and Jun Li, San Bruno, CA (US)
Assigned to Genentech, Inc., South San Francisco, CA (US)
Filed by Genentech, Inc., South San Francisco, CA (US)
Filed on Feb. 25, 2021, as Appl. No. 17/185,319.
Application 17/185,319 is a continuation of application No. 15/955,539, filed on Apr. 17, 2018, granted, now 10,966,963.
Application 15/955,539 is a continuation of application No. 14/972,326, filed on Dec. 17, 2015, granted, now 9,980,947, issued on May 29, 2019.
Claims priority of provisional application 62/142,077, filed on Apr. 2, 2015.
Claims priority of provisional application 62/110,998, filed on Feb. 2, 2015.
Claims priority of provisional application 62/093,929, filed on Dec. 18, 2014.
Prior Publication US 2021/0236473 A1, Aug. 5, 2021
Prior Publication US 2023/0045776 A9, Feb. 9, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/437 (2006.01); A61K 31/138 (2006.01); A61K 31/4545 (2006.01); A61K 31/497 (2006.01); A61K 31/506 (2006.01); A61K 31/565 (2006.01); A61K 45/06 (2006.01); C07D 471/04 (2006.01); A61P 5/30 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01)
CPC A61K 31/437 (2013.01) [A61K 31/138 (2013.01); A61K 31/4545 (2013.01); A61K 31/497 (2013.01); A61K 31/506 (2013.01); A61K 31/565 (2013.01); A61K 45/06 (2013.01); C07D 471/04 (2013.01)] 32 Claims
 
1. A process for preparing a compound of formula (14),

OG Complex Work Unit Chemistry
or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof,
wherein:
Ra is independently selected from H, C1-C6 alkyl, C2-C8 alkenyl, propargyl, C3-C6 cycloalkyl, and C3-C6 heterocyclyl, optionally substituted with one or more groups independently selected from F, Cl, Br, I, CN, OH, OCH3, and SO2CH3;
Rb is H;
Z2 is NH;
R1 and R2 are each H;
R3 and R4 are independently selected from H, F, Cl, Br, I, —CN, —CH3, —CH2CH3, —CH(CH3)2, —CH2CH(CH3)2, —CH2OH, —CH2OCH3, —CH2CH2OH, —C(CH3)2OH, —CH(OH)CH(CH3)2, —C(CH3)2CH2OH, —CH2CH2SO2CH3, —CH2OP(O)(OH)2, —CH2F, —CHF2, —CH2NH2, —CH2NHSO2CH3, —CH2NHCH3, —CH2N(CH3)2, —CF3, —CH2CF3, —CH2CHF2, —CH(CH3)CN, —C(CH3)2CN, —CH2CN, —CO2H, —COCH3, —CO2CH3, —CO2C(CH3)3, —COCH(OH)CH3, —CONH2, —CONHCH3, —CONHCH2CH3, —CONHCH(CH3)2, —CON(CH3)2, —C(CH3)2CONH2, —NH2, —NHCH3, —N(CH3)2, —NHCOCH3, —N(CH3) COCH3, —NHS(O)2CH3, —N(CH3)C(CH3)2CONH2, —N(CH3)CH2CH2S(O)2CH3, —NO2, ═O, —OH, —OCH3, —OCH2CH3, —OCH2CH2OCH3, —OCH2CH2OH, —OCH2CH2N(CH3)2, —OP(O)(OH)2, —S(O)2N(CH3)2, —SCH3, —S(O)2CH3, —S(O)3H, cyclopropyl, cyclopropylamide, cyclobutyl, oxetanyl, azetidinyl, 1-methylazetidin-3-yl)oxy, N-methyl-N-oxetan-3-ylamino, azetidin-1-ylmethyl, benzyloxyphenyl, pyrrolidin-1-yl, pyrrolidin-1-yl-methanone, piperazin-1-yl, morpholinomethyl, morpholino-methanone, and morpholino;
R5 is selected from H, C1-C9 alkyl, C3-C9 cycloalkyl, C3-C9 heterocycle, C6-C9 aryl, C6-C9 heteroaryl, —(C1-C6 alkyldiyl)-(C3-C9 cycloalkyl), —(C1-C6 alkyldiyl)-(C3-C9 heterocycle), C(O)Rb, C(O)NRa, SO2Ra, and SO2NRa, optionally substituted with one or more of halogen, CN, ORa, N(Ra)2, C1-C9 alkyl, C3-C9 cycloalkyl, C3-C9 heterocycle, C6-C9 aryl, C6-C9 heteroaryl, C(O)Rb, C(O)NRa, SO2Ra, and SO2NRa;
each R6 and R7 is independently F or Cl;
m is selected from 0, 1, 2, 3, and 4; and
n is selected from 0, 1, 2, 3, and 4;
the process comprising:
(a) contacting a compound of formula:

OG Complex Work Unit Chemistry
with a compound of formula X—R5, wherein X is I, Br, or —OTf, thereby synthesizing a compound having formula (12):

OG Complex Work Unit Chemistry
(b) cyclizing the compound of formula (12) with a compound of formula:

OG Complex Work Unit Chemistry
wherein X1 is Br or I, thereby synthesizing a compound having formula (13)

OG Complex Work Unit Chemistry
wherein X1 is I or Br; and
(c) reacting the compound of formula (13) with a compound having formula

OG Complex Work Unit Chemistry
(d) contacting the compound of step (c) with an acid to remove the Boc moiety thereby synthesizing a free amine; and
(e) contacting the compound of step (d) with a compound of formula I—Ra;
thereby synthesizing a compound having formula (14).